Decitabine Plus mBU/CY Preconditioning for Relapse/Refractory Acute Leukemia

Clinical trial NCT03799224 · UNKNOWN

Trial details

NCT number: NCT03799224
Sponsor: Peking University People's Hospital
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Stem Cell Transplant Complications Relapse Leukemia Refractory Leukemia

Start date: 2018-12-01
Primary completion: 2021-12-31
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.